Last 12 months
Inside the activity.
0 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2024 Filed Oct 3, 2024 20:25 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantStock Option (Right to Buy) · Derivative | 18,623 | $0.00 Strike: $173.04 | $0.00 |
DisclosureSEC source: 0001127602-24-025120 · form4.xml · derivative · entry 4 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,623 Underlying: Common Stock · 18,623 shares Expires 2034-09-29 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:25 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantCommon Stock | 3,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025120 · form4.xml · nonDerivative · entry 1 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,934.7898 F1 · price: Restricted Stock Units awarded pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:26 UTC |
Davis Jennifer L.CEO - Health Care
|
GrantStock Option (Right to Buy) · Derivative | 56,554 | $0.00 Strike: $173.04 | $0.00 |
DisclosureSEC source: 0001127602-24-025122 · form4.xml · derivative · entry 3 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,554 Underlying: Common Stock · 56,554 shares Expires 2034-09-29 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:27 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 180,388 | $0.00 Strike: $173.04 | $0.00 |
DisclosureSEC source: 0001127602-24-025123 · form4.xml · derivative · entry 5 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,388 Underlying: Common Stock · 180,388 shares Expires 2034-09-29 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:27 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
GrantCommon Stock | 12,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025123 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,178.8949 F1 · price: Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:29 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
GrantStock Option (Right to Buy) · Derivative | 10,944 | $0.00 Strike: $173.04 | $0.00 |
DisclosureSEC source: 0001127602-24-025124 · form4.xml · derivative · entry 4 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,944 Underlying: Common Stock · 10,944 shares Expires 2034-09-29 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:29 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
GrantCommon Stock | 6,903 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025124 · form4.xml · nonDerivative · entry 1 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,975.1201 F1 · price: Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 18:20 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantStock Option (Right to Buy) · Derivative | 5,932 | $0.00 Strike: $174.08 | $0.00 |
DisclosureSEC source: 0001127602-24-023971 · form4.xml · derivative · entry 4 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,932 Underlying: Common Stock · 5,932 shares Expires 2034-09-13 Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 18:24 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantStock Option (Right to Buy) · Derivative | 2,049 | $0.00 Strike: $174.08 | $0.00 |
DisclosureSEC source: 0001127602-24-023973 · form4.xml · derivative · entry 5 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 2,049 Underlying: Common Stock · 2,049 shares Expires 2034-09-13 Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 18:23 UTC |
Jejurikar ShaileshChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 13,046 | $0.00 Strike: $174.08 | $0.00 |
DisclosureSEC source: 0001127602-24-023972 · form4.xml · derivative · entry 5 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,046 Underlying: Common Stock · 13,046 shares Expires 2034-09-13 Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 18:28 UTC |
Purushothaman BalajiChief Human Resources Officer
|
GrantStock Option (Right to Buy) · Derivative | 10,593 | $0.00 Strike: $174.08 | $0.00 |
DisclosureSEC source: 0001127602-24-023974 · form4.xml · derivative · entry 3 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,593 Underlying: Common Stock · 10,593 shares Expires 2034-09-13 Read SEC document |
| September 10, 2024 Filed Sep 11, 2024 18:14 UTC |
Allen Bertrand MarcDirector
|
GrantCommon Stock | 169 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023763 · form4.xml · nonDerivative · entry 1 Allen Bertrand Marc · CIK 0001632131 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,742.9845 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 10, 2024 Filed Sep 11, 2024 18:15 UTC |
Biggs M. BrettDirector
|
GrantCommon Stock | 169 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023764 · form4.xml · nonDerivative · entry 1 Biggs M. Brett · CIK 0001662848 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,252.5285 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 10, 2024 Filed Sep 11, 2024 18:17 UTC |
JIMENEZ JOSEPHDirector
|
GrantCommon Stock | 268 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023765 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,154.5277 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 10, 2024 Filed Sep 11, 2024 18:18 UTC |
Kempczinski Christopher JDirector
|
GrantCommon Stock | 169 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023766 · form4.xml · nonDerivative · entry 1 Kempczinski Christopher J · CIK 0001598115 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,936.5316 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units Read SEC document |
| September 10, 2024 Filed Sep 11, 2024 18:19 UTC |
LUNDGREN TERRY JDirector
|
GrantCommon Stock | 204 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023767 · form4.xml · nonDerivative · entry 1 LUNDGREN TERRY J · CIK 0001184471 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,209.8003 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| September 10, 2024 Filed Sep 11, 2024 18:20 UTC |
McCarthy Christine MDirector
|
GrantCommon Stock | 211 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023768 · form4.xml · nonDerivative · entry 1 McCarthy Christine M · CIK 0001332169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,403.1456 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock & Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 10, 2024 Filed Sep 11, 2024 18:21 UTC |
McEvoy AshleyDirector
|
GrantCommon Stock | 169 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023769 · form4.xml · nonDerivative · entry 1 McEvoy Ashley · CIK 0001745936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,773.6443 F1 · price: Common Stock awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 10, 2024 Filed Sep 11, 2024 18:22 UTC |
Portman Robert JonesDirector
|
GrantCommon Stock | 43 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023770 · form4.xml · nonDerivative · entry 1 Portman Robert Jones · CIK 0001973769 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,844.6365 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units Read SEC document |
| September 10, 2024 Filed Sep 11, 2024 18:24 UTC |
WOERTZ PATRICIA ADirector
|
GrantCommon Stock | 169 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023771 · form4.xml · nonDerivative · entry 1 WOERTZ PATRICIA A · CIK 0001194945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,274.2319 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| August 28, 2024 Filed Aug 29, 2024 17:50 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
SaleCommon Stock | 37,240 | $168.89 | $6,289,642.35 |
DisclosureSEC source: 0001127602-24-023120 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 263,536.8949 F1 · price: Weighted average price of the shares sold. The price range was $168.85 to $168.97. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 26, 2024 Filed Aug 27, 2024 13:24 UTC |
Schulten AndreChief Financial Officer
|
SaleCommon Stock | 13,041 | $170.00 | $2,216,970.00 |
DisclosureSEC source: 0001127602-24-022943 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,208.2045 Read SEC document |
| August 26, 2024 Filed Aug 27, 2024 13:25 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 87,979 | $0.00 Strike: $98.55 | $0.00 |
DisclosureSEC source: 0001127602-24-022944 · form4.xml · derivative · entry 5 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 87,979 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 26, 2024 Filed Aug 27, 2024 13:25 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
SaleCommon Stock | 87,979 | $170.40 | $14,991,815.15 |
DisclosureSEC source: 0001127602-24-022944 · form4.xml · nonDerivative · entry 2 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,776.8949 F1 · price: Weighted average price of the shares sold. The price range was $170.32 to $170.48. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 26, 2024 Filed Aug 27, 2024 13:25 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 87,979 | $98.55 | $8,670,330.45 |
DisclosureSEC source: 0001127602-24-022944 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 388,755.8949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2024 Filed Aug 26, 2024 17:54 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 12,852 | $170.05 | $2,185,482.60 |
DisclosureSEC source: 0001127602-24-022902 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,453.1608 Read SEC document |
| August 23, 2024 Filed Aug 26, 2024 17:54 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 880 | $170.05 | $149,644.00 |
DisclosureSEC source: 0001127602-24-022902 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 4,241.9748 Read SEC document |
| August 23, 2024 Filed Aug 26, 2024 17:55 UTC |
Jejurikar ShaileshChief Operating Officer
|
SaleCommon Stock | 14,034 | $169.78 | $2,382,724.80 |
DisclosureSEC source: 0001127602-24-022903 · form4.xml · nonDerivative · entry 1 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,855.9125 F1 · price: Weighted average price of the shares sold. The price range was $169.75 to $169.93. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 22, 2024 Filed Aug 23, 2024 13:52 UTC |
Coombe Gary ACEO - Grooming
|
SaleCommon Stock | 12,249 | $170.03 | $2,082,684.00 |
DisclosureSEC source: 0001127602-24-022820 · form4.xml · nonDerivative · entry 2 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,960.9678 F3 · price: Weighted average price of the shares sold. The price range was $170.01 to $170.10. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 22, 2024 Filed Aug 23, 2024 14:58 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 96,000 | $0.00 Strike: $98.55 | $0.00 |
DisclosureSEC source: 0001127602-24-022823 · form4.xml · derivative · entry 5 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 96,000 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2024 Filed Aug 23, 2024 14:58 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
SaleCommon Stock | 96,000 | $170.00 | $16,320,000.00 |
DisclosureSEC source: 0001127602-24-022823 · form4.xml · nonDerivative · entry 2 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,721.3362 F1 · price: Weighted average price of the shares sold. The price range was $170.00 to $170.01. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 22, 2024 Filed Aug 23, 2024 14:58 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
Exercise / conversionCommon Stock | 96,000 | $98.55 | $9,460,800.00 |
DisclosureSEC source: 0001127602-24-022823 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,721.3362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 21, 2024 Filed Aug 22, 2024 21:02 UTC |
Purushothaman BalajiChief Human Resources Officer
|
SaleCommon Stock | 1,111 | $170.51 | $189,436.61 |
DisclosureSEC source: 0001127602-24-022807 · form4.xml · nonDerivative · entry 2 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,565.9989 Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 12:45 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 729 | $170.59 | $124,363.68 |
DisclosureSEC source: 0001127602-24-022817 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 5,121.9748 F1 · shares: Shares sold to cover taxes on Stock Award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 12:45 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 10,627 | $170.59 | $1,812,912.00 |
DisclosureSEC source: 0001127602-24-022817 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,305.1608 F1 · shares: Shares sold to cover taxes on Stock Award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 13:37 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
SaleCommon Stock | 8,990 | $170.59 | $1,533,648.15 |
DisclosureSEC source: 0001127602-24-022819 · form4.xml · nonDerivative · entry 1 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,915.3465 F1 · shares: Shares sold to cover taxes on Stock Award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 13:52 UTC |
Coombe Gary ACEO - Grooming
|
SaleCommon Stock | 10,128 | $170.59 | $1,727,785.15 |
DisclosureSEC source: 0001127602-24-022820 · form4.xml · nonDerivative · entry 1 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,209.9678 F1 · shares: Shares sold to cover taxes on Stock Award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 20:30 UTC |
Schulten AndreChief Financial Officer
|
SaleCommon Stock | 9,150 | $169.22 | $1,548,353.85 |
DisclosureSEC source: 0001127602-24-022792 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,249.2045 F1 · shares: Shares sold to cover taxes on Stock Award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 20:31 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
SaleCommon Stock | 6,163 | $169.22 | $1,042,896.70 |
DisclosureSEC source: 0001127602-24-022794 · form4.xml · nonDerivative · entry 1 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,018.7898 F1 · shares: Shares sold to cover taxes on Stock Award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 20:32 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
SaleCommon Stock | 9,844 | $169.22 | $1,665,791.84 |
DisclosureSEC source: 0001127602-24-022795 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,721.3362 F1 · shares: Shares sold to cover taxes on Stock Award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 20:58 UTC |
Jejurikar ShaileshChief Operating Officer
|
SaleCommon Stock | 10,623 | $169.22 | $1,797,613.44 |
DisclosureSEC source: 0001127602-24-022801 · form4.xml · nonDerivative · entry 1 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,889.9125 F1 · shares: Shares sold to cover taxes on Stock Award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 20:59 UTC |
Davis Jennifer L.CEO - Health Care
|
SaleCommon Stock | 6,223 | $169.22 | $1,053,049.84 |
DisclosureSEC source: 0001127602-24-022803 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,319.0851 F1 · shares: Shares sold to cover taxes on Stock Award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 21:01 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
SaleCommon Stock | 31,797 | $169.22 | $5,380,656.54 |
DisclosureSEC source: 0001127602-24-022805 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,776.8949 F1 · shares: Shares sold to cover taxes on Stock Award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 21:02 UTC |
Purushothaman BalajiChief Human Resources Officer
|
SaleCommon Stock | 920 | $169.22 | $155,681.48 |
DisclosureSEC source: 0001127602-24-022807 · form4.xml · nonDerivative · entry 1 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,676.9989 F1 · shares: Shares sold to cover taxes on Stock Award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 21:03 UTC |
Pritchard Marc S.Chief Brand Officer
|
SaleCommon Stock | 9,522 | $169.22 | $1,611,303.32 |
DisclosureSEC source: 0001127602-24-022810 · form4.xml · nonDerivative · entry 1 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,665.4817 F1 · shares: Shares sold to cover taxes on Stock Award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 21:05 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
SaleCommon Stock | 450 | $169.22 | $76,148.55 |
DisclosureSEC source: 0001127602-24-022812 · form4.xml · nonDerivative · entry 1 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,072.1201 F1 · shares: Shares sold to cover taxes on Stock Award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 19, 2024 Filed Aug 20, 2024 20:51 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
GrantCommon Stock | 69,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022620 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 332,194.512 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| August 19, 2024 Filed Aug 20, 2024 20:53 UTC |
Purushothaman BalajiChief Human Resources Officer
|
GrantCommon Stock | 2,031 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022622 · form4.xml · nonDerivative · entry 1 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,567.6537 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| August 19, 2024 Filed Aug 20, 2024 20:54 UTC |
Schulten AndreChief Financial Officer
|
GrantCommon Stock | 22,191 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022623 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,212.957 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| August 19, 2024 Filed Aug 20, 2024 20:55 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantCommon Stock | 14,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022625 · form4.xml · nonDerivative · entry 1 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,149.4881 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.